Study analysis · Neurobiology of disease · 2025
Endurance athletes have LESS of this 'exercise hormone'—and it might be a good thing.
People who train super hard for years have lower levels of a hormone called irisin, and in sedentary Parkinson’s patients, higher irisin means worse symptoms.
Overview
What the study found
The study in plain English — the bottom line, every takeaway we extracted, and what to do with them.
In simple terms
This study looked at people who exercise a lot and people who don’t, and noticed that those who exercise had different blood levels of a protein called irisin and felt better. But it didn’t make anyone start or stop exercising — so we can’t say exercise caused the improvement.
What’s the bottom line?
This study looked at how much of a hormone called irisin is in the blood of people with Parkinson’s and healthy people, depending on whether they exercise a lot or sit around.
How strong is this study?
The study did a good job measuring things like symptoms and blood levels, but since it just watched people instead of changing their habits, we can’t be sure if exercise really helped or if other things (like diet or sleep) made the difference. That’s why we need to be careful about what we conclude.
0 / 100
- COI disclosureconflicts of interest not disclosed
- Data availabilitydata not shared
- Code availabilitycode not shared
28 / 100
- Randomizationnot randomized
- Blindingblinding unclear
- Control group+15/15
- Sample size (n=93)+7.4/20
- Follow-upno follow-up reported
100 / 100
23 / 100
- P-values+15/15
- Effect sizeno effect size reported
- Confidence intervalsno confidence intervals
- Pre-registrationnot pre-registered
Each component is scored out of 100 and then capped by the study design — a case series cannot reach the ceiling a randomised trial can, however well it is reported.
Where it sits
RCT reviewsReviews of RCTs (Meta-analyses)
Max 100Randomized TrialsRandomized Trials
Max 90Reviews of Cohort StudiesReviews of Cohort Studies
Max 85Cohort StudiesCohort Studies
Max 72Reviews of Case-Control StudiesReviews of Case-Control Studies
Max 63Case-Control StudiesCase-Control Studies
Max 58Cross-Sectional & Case SeriesCross-Sectional & Case Series
Max 50Expert OpinionExpert Opinion
Max 536 / 100
Probability of being correct
Snapshots of a population at a single point in time, or descriptions of small groups. Can identify correlations and prevalence, but cannot determine cause and effect.
This design cannot establish causation — the findings describe an association, not a cause. This is an observational cross-sectional study with no randomization; it can only show associations, not cause-and-effect relationships. The study compares groups based on existing exercise habits and disease status, so confounding factors (like disease duration, medication, or lifestyle) may explain the results.
No Conflicts
No conflicts of interest identified
No conflicts of interest or funding information were disclosed in the provided text.
The study lacks any declaration of funding, conflicts of interest, or author affiliations. While the findings are internally consistent, the absence of transparency limits assessment of potential bias.
Key takeaways
- 01
People who trained hard for years (like marathon runners) had lower irisin levels than sedentary people.
- 02
In sedentary Parkinson’s patients, higher irisin meant worse movement symptoms and higher drug doses.
- 03
Men had lower irisin than women.
- 04
It’s surprising that intense exercise lowers irisin — the opposite of what some expected — and in sedentary Parkinson’s patients, more irisin might mean worse disease, suggesting it could be a marker, not a helper.
Surprising findings
- Chronic intense endurance exercise is associated with lower plasma irisin levels.Irisin is widely believed to be released during exercise as a beneficial myokine—so finding that elite athletes have less of it contradicts the dominant narrative.
Practical takeaways
Don’t assume higher irisin means better health—especially in Parkinson’s.
This is an observational study; we don’t know if irisin causes symptoms or is just correlated. No intervention was tested.
low confidenceWhy this study matters
Irisin drops in elite athletes
Endurance athletes—whether they have Parkinson’s or not—had significantly lower plasma irisin levels than sedentary individuals. For example, PD-EA vs PD-SD: p=0.002; HC-EA vs HC-SD: p=0.046.
We assume exercise boosts irisin, but this study shows the opposite: years of intense training may actually suppress it, flipping the script on what we thought we knew about exercise biomarkers.
Higher irisin = worse Parkinson’s symptoms
In sedentary Parkinson’s patients, higher irisin levels correlated with worse motor symptoms (r=0.395, p=0.034) and higher levodopa doses (r=0.385, p=0.043).
This suggests irisin might not be a healing hormone in Parkinson’s—it could be a marker of disease severity, not a protector. That’s the opposite of what most assume.
Men have lower irisin than women
Lower plasma irisin levels were strongly associated with male sex (p<0.001), regardless of Parkinson’s status or exercise level.
This could explain sex differences in Parkinson’s progression or response to exercise—and hints that irisin regulation is biologically tied to sex hormones.
Want the whole report?
Detailed mode opens the full scientific breakdown — every score component, the methodology, conflicts of interest, the evidence analysis behind each claim, and the raw study data.
Overview
What the study found
The study in plain English — the bottom line, every takeaway we extracted, and what to do with them.
Not medical advice. For informational purposes only. Always consult a healthcare professional. Terms
This study looked at how much of a hormone called irisin is in the blood of people with Parkinson’s and healthy people, depending on whether they exercise a lot or sit around.
Research results
People who trained hard for years (like marathon runners) had lower irisin levels than sedentary people. In sedentary Parkinson’s patients, higher irisin meant worse movement symptoms and higher drug doses. Men had lower irisin than women.
What this means - more context
It’s surprising that intense exercise lowers irisin — the opposite of what some expected — and in sedentary Parkinson’s patients, more irisin might mean worse disease, suggesting it could be a marker, not a helper.
The study investigates whether chronic, intense endurance exercise affects plasma irisin levels in individuals with Parkinson’s disease (PD) and healthy controls, and whether irisin correlates with motor symptoms.
Plasma irisin was lower in endurance athletes than sedentary participants, regardless of PD status. In sedentary PD individuals, higher irisin correlated with worse motor symptoms and higher levodopa dose. Lower irisin was associated with male sex in both groups.
Methods Used
Cross-sectional comparison of 93 participants divided into four groups based on PD status and exercise level (sedentary vs. endurance athletes). Plasma irisin was measured; clinical assessments included MDS-UPDRS Part III, MMSE, and levodopa equivalent daily dose.
Main Finding
Chronic, intense endurance exercise was associated with lower plasma irisin levels in both PD and healthy individuals. In sedentary PD patients, higher irisin correlated with worse motor symptoms (MDS-UPDRS Part III) and higher levodopa dose. Lower irisin levels were associated with male sex.
Confidence Level
Limited - based on abstract only, full methodology not available
Study Flags
Red Flags
- •Full text not available - methodology details cannot be verified
- •No randomization or intervention — observational only
- •Effect sizes not reported, only p-values
Surprising Findings
Chronic intense endurance exercise is associated with lower plasma irisin levels.
Irisin is widely believed to be released during exercise as a beneficial myokine—so finding that elite athletes have less of it contradicts the dominant narrative.
Practical Takeaways
Don’t assume higher irisin means better health—especially in Parkinson’s.
RCT reviewsReviews of RCTs (Meta-analyses)
Max 100Randomized TrialsRandomized Trials
Max 90Reviews of Cohort StudiesReviews of Cohort Studies
Max 85Cohort StudiesCohort Studies
Max 72Reviews of Case-Control StudiesReviews of Case-Control Studies
Max 63Case-Control StudiesCase-Control Studies
Max 58Cross-Sectional & Case SeriesCross-Sectional & Case Series
Max 50Expert OpinionExpert Opinion
Max 536 / 100
Probability of being correct
Snapshots of a population at a single point in time, or descriptions of small groups. Can identify correlations and prevalence, but cannot determine cause and effect.
Human Cross-Sectional
Subject
Lower probability
on the GRADE evidence scale
This study looked at people who exercise a lot and people who don’t, and noticed that those who exercise had different blood levels of a protein called irisin and felt better. But it didn’t make anyone start or stop exercising — so we can’t say exercise caused the improvement.
No conflicts of interest were detected in this study. No score impact.
Strengths
- Clear grouping of participants by disease status and exercise level
- Use of validated clinical scales (MDS-UPDRS, MMSE)
- Reasonable sample size for an observational study
Weaknesses
- Full methodology not available - based on abstract only
- Cross-sectional design cannot determine temporal sequence or causality
- No adjustment for potential confounders like diet, sleep, or medication dosage beyond LEDD
Methodology
Evidence Keywords
Statistical Reporting
Not medical advice. For informational purposes only. Always consult a healthcare professional. Terms
This study looked at how much of a hormone called irisin is in the blood of people with Parkinson’s and healthy people, depending on whether they exercise a lot or sit around.
Research results
People who trained hard for years (like marathon runners) had lower irisin levels than sedentary people. In sedentary Parkinson’s patients, higher irisin meant worse movement symptoms and higher drug doses. Men had lower irisin than women.
What this means - more context
It’s surprising that intense exercise lowers irisin — the opposite of what some expected — and in sedentary Parkinson’s patients, more irisin might mean worse disease, suggesting it could be a marker, not a helper.
The study investigates whether chronic, intense endurance exercise affects plasma irisin levels in individuals with Parkinson’s disease (PD) and healthy controls, and whether irisin correlates with motor symptoms.
Plasma irisin was lower in endurance athletes than sedentary participants, regardless of PD status. In sedentary PD individuals, higher irisin correlated with worse motor symptoms and higher levodopa dose. Lower irisin was associated with male sex in both groups.
Methods Used
Cross-sectional comparison of 93 participants divided into four groups based on PD status and exercise level (sedentary vs. endurance athletes). Plasma irisin was measured; clinical assessments included MDS-UPDRS Part III, MMSE, and levodopa equivalent daily dose.
Main Finding
Chronic, intense endurance exercise was associated with lower plasma irisin levels in both PD and healthy individuals. In sedentary PD patients, higher irisin correlated with worse motor symptoms (MDS-UPDRS Part III) and higher levodopa dose. Lower irisin levels were associated with male sex.
Confidence Level
Limited - based on abstract only, full methodology not available
Study Flags
Red Flags
- •Full text not available - methodology details cannot be verified
- •No randomization or intervention — observational only
- •Effect sizes not reported, only p-values
Surprising Findings
Chronic intense endurance exercise is associated with lower plasma irisin levels.
Irisin is widely believed to be released during exercise as a beneficial myokine—so finding that elite athletes have less of it contradicts the dominant narrative.
Practical Takeaways
Don’t assume higher irisin means better health—especially in Parkinson’s.
RCT reviewsReviews of RCTs (Meta-analyses)
Max 100Randomized TrialsRandomized Trials
Max 90Reviews of Cohort StudiesReviews of Cohort Studies
Max 85Cohort StudiesCohort Studies
Max 72Reviews of Case-Control StudiesReviews of Case-Control Studies
Max 63Case-Control StudiesCase-Control Studies
Max 58Cross-Sectional & Case SeriesCross-Sectional & Case Series
Max 50Expert OpinionExpert Opinion
Max 536 / 100
Probability of being correct
Snapshots of a population at a single point in time, or descriptions of small groups. Can identify correlations and prevalence, but cannot determine cause and effect.
Human Cross-Sectional
Subject
Lower probability
on the GRADE evidence scale
This study looked at people who exercise a lot and people who don’t, and noticed that those who exercise had different blood levels of a protein called irisin and felt better. But it didn’t make anyone start or stop exercising — so we can’t say exercise caused the improvement.
No conflicts of interest were detected in this study. No score impact.
Strengths
- Clear grouping of participants by disease status and exercise level
- Use of validated clinical scales (MDS-UPDRS, MMSE)
- Reasonable sample size for an observational study
Weaknesses
- Full methodology not available - based on abstract only
- Cross-sectional design cannot determine temporal sequence or causality
- No adjustment for potential confounders like diet, sleep, or medication dosage beyond LEDD
Methodology
Evidence Keywords
Statistical Reporting
Scoring
How strong is this study?
The study did a good job measuring things like symptoms and blood levels, but since it just watched people instead of changing their habits, we can’t be sure if exercise really helped or if other things (like diet or sleep) made the difference. That’s why we need to be careful about what we conclude.
0 / 100
- COI disclosureconflicts of interest not disclosed
- Data availabilitydata not shared
- Code availabilitycode not shared
28 / 100
- Randomizationnot randomized
- Blindingblinding unclear
- Control group+15/15
- Sample size (n=93)+7.4/20
- Follow-upno follow-up reported
100 / 100
23 / 100
- P-values+15/15
- Effect sizeno effect size reported
- Confidence intervalsno confidence intervals
- Pre-registrationnot pre-registered
Each component is scored out of 100 and then capped by the study design — a case series cannot reach the ceiling a randomised trial can, however well it is reported.
Where it sits
RCT reviewsReviews of RCTs (Meta-analyses)
Max 100Randomized TrialsRandomized Trials
Max 90Reviews of Cohort StudiesReviews of Cohort Studies
Max 85Cohort StudiesCohort Studies
Max 72Reviews of Case-Control StudiesReviews of Case-Control Studies
Max 63Case-Control StudiesCase-Control Studies
Max 58Cross-Sectional & Case SeriesCross-Sectional & Case Series
Max 50Expert OpinionExpert Opinion
Max 536 / 100
Probability of being correct
Snapshots of a population at a single point in time, or descriptions of small groups. Can identify correlations and prevalence, but cannot determine cause and effect.
This design cannot establish causation — the findings describe an association, not a cause. This is an observational cross-sectional study with no randomization; it can only show associations, not cause-and-effect relationships. The study compares groups based on existing exercise habits and disease status, so confounding factors (like disease duration, medication, or lifestyle) may explain the results.
No Conflicts
No conflicts of interest identified
No conflicts of interest or funding information were disclosed in the provided text.
The study lacks any declaration of funding, conflicts of interest, or author affiliations. While the findings are internally consistent, the absence of transparency limits assessment of potential bias.